Quote For Bioniche Life Sciences Inc. BNC.TO

Bioniche Life Sciences Inc. (BNC.TO) (Toronto Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  3 Dec 2009
0.43CAD
Price Change
+0.02
Percent Change
+4.94%
 
Research a stock:   symbol lookup
$0.43
3 Dec 2009
+4.94%
$0.43
--
75,200
$0.43
$0.41
$0.75
$0.30
0.52
94,165

News

Press Releases

No news stories for this company within the last 30 days.

Key Developments

Officers

Name Current Position Compensation
McRae, Graeme Chairman of the Board, President, Chief Executive Officer 377,549
Ford, Brian Chief Financial Officer --
Beraldo, Albert Director; President of Alveda Pharmaceuticals Inc. --

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) $30.58
Shares Outstanding (Mil.) 71.96
Float (Mil.) 63.27
Dividend Information
Yield % --
Annual Dividend ($ CAD) 0.00
Payout Ratio(TTM) % --
Financial Strength
Quick Ratio 0.66
Current Ratio 2.90
LT Debt/Equity 92.71
Total Debt/Equity 154.55
Valuation Ratios
Price/Earnings(TTM) --
Price/Sales(TTM) 0.95
Price/Book(TTM) 12.31
Price/Cash Flow(TTM) --
Per Share Data
Earnings(TTM) $-0.20
Sales(TTM) $0.45
Book Value(MRQ) $0.03
Cash Flow(TTM) $-0.16
Cash(MRQ) $0.19
Management Effectiveness
Return on Equity(TTM) -311.51
Return on Assets(TTM) -36.19
Return on Investment(TTM) -49.57
Margins
Gross Margin(TTM) % 57.08
Operating Margin(TTM) % -41.89
Profit Margin(TTM) % -43.22

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement